These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 17543637

  • 1. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R, Allison MA, Criqui MH.
    J Am Coll Cardiol; 2007 Jun 05; 49(22):2172-81. PubMed ID: 17543637
    [Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S, Webb MC, Price CP, John RI, Abbas NA, Lamb EJ.
    Nephrol Dial Transplant; 2008 Nov 03; 23(11):3546-53. PubMed ID: 18562472
    [Abstract] [Full Text] [Related]

  • 5. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.
    Kidney Blood Press Res; 2009 Nov 03; 32(5):373-9. PubMed ID: 19887825
    [Abstract] [Full Text] [Related]

  • 6. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C, Reinecke H, Stypmann J, Rothenburger M, Schmid C, Breithardt G, Wichter T, Gradaus R.
    J Heart Lung Transplant; 2006 Sep 03; 25(9):1135-41. PubMed ID: 16962477
    [Abstract] [Full Text] [Related]

  • 7. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.
    Am J Cardiol; 2008 Jan 01; 101(1):122-6. PubMed ID: 18157978
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians.
    Vaes B, de Ruijter W, Degryse J, Westendorp RG, Gussekloo J.
    J Am Geriatr Soc; 2009 May 01; 57(5):823-9. PubMed ID: 19470010
    [Abstract] [Full Text] [Related]

  • 9. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
    Eggers KM, Venge P, Lind L.
    Am J Cardiol; 2013 Jan 01; 111(1):131-6. PubMed ID: 23040598
    [Abstract] [Full Text] [Related]

  • 10. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov 01; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):357-64. PubMed ID: 19608034
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M, Tarnow L, Jorsal A, Parving HH.
    Nephrol Dial Transplant; 2007 Nov 21; 22(11):3235-9. PubMed ID: 17567649
    [Abstract] [Full Text] [Related]

  • 13. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, Cameron R, Krauser DG, Tung R, Camargo CA, Lloyd-Jones DM.
    Arch Intern Med; 2006 Feb 13; 166(3):315-20. PubMed ID: 16476871
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan 13; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

  • 15. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 13; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 16. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D, Koenig W, Brenner H.
    Arch Intern Med; 2009 May 13; 166(22):2455-60. PubMed ID: 17159010
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD, Kumar S, Worthington AM, Burgess D.
    Anesthesiology; 2009 Aug 13; 111(2):311-9. PubMed ID: 19602961
    [Abstract] [Full Text] [Related]

  • 18. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.
    Dieplinger B, Haltmayer M, Poelz W, Mueller T.
    Clin Chim Acta; 2009 Oct 13; 408(1-2):87-91. PubMed ID: 19646980
    [Abstract] [Full Text] [Related]

  • 19. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D.
    Nephrol Dial Transplant; 2010 Feb 13; 25(2):551-7. PubMed ID: 19679559
    [Abstract] [Full Text] [Related]

  • 20. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
    Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D.
    Heart; 2007 Feb 13; 93(2):226-31. PubMed ID: 16914484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.